ARC
WST icon

Absolute Return Capital’s West Pharmaceutical WST Stock Holding History

Absolute Return Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,924
Closed -$545K – 965
2014
Q2 		$545K Buy
+12,924
New +$553K 0.01% 822

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Absolute Return Capital's WST Position: Q3 2014 in Review

Absolute Return Capital sold out of West Pharmaceutical (WST) in Q3 2014, closing a stake of 12,924 shares — an estimated $545K sold.

Absolute Return Capital first reported a position in WST in Q2 2014 and held it in 1 quarter. The position peaked at $545K in Q2 2014. 213 funds tracked by Wall St. Rank hold WST as of Q3 2014.

  • Absolute Return Capital reported no remaining West Pharmaceutical position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 12,924 West Pharmaceutical shares in Q3 2014, an estimated $545K.
  • Absolute Return Capital first reported a position in West Pharmaceutical in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's West Pharmaceutical position peaked at $545K in Q2 2014.
  • 213 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.